Actions for Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014

Email RIS file
Bookmark
Report an Issue

Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014

Corporate Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Published
Washington : U.S. Government Publishing Office, 2015.
Physical Description
1 online resource (iv, 217 pages)
Access Online

Availability

I Want It
I Want It

Finding items...

Restrictions on Access
Free-to-read Unrestricted online access
Report Numbers
Y 4.C 73/8:113-137
Serial no. 113-137 (United States. Congress. House. Committee on Energy and Commerce)
Subject(s)
Genre(s)
Note
Title from title screen (viewed on July 24, 2015).
Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
"Serial No. 113-147."
Bibliography Note
Includes bibliographical references.
Action Note
committed to retain. Federal Depository Library Program (FDLP). For information on our retention commitment, please contact Microforms and Government Information.
View MARC record | catkey: 15750588